Rchr
J-GLOBAL ID:201701006679739378   Update date: Jun. 24, 2024

Mori Kenta

モリ ケンタ | Mori Kenta
Affiliation and department:
Research field  (2): Cardiology ,  Internal medicine - General
Papers (34):
  • Shunsuke Katsuki, Tetsuya Matoba, Yusuke Akiyama, Hiroshi Yoshida, Kazuhiko Kotani, Hisako Fujii, Mariko Harada-Shiba, Yutaka Ishibashi, Tatsuro Ishida, Yasushi Ishigaki, et al. Association of Serum Levels of Cholesterol Absorption and Synthesis Markers with the Presence of Cardiovascular Disease: The CACHE Study CVD Analysis. Journal of atherosclerosis and thrombosis. 2023. 30. 12. 1766-1777
  • Mitsumasa Okano, Katsuhiko Yoneda, Yoshihide Ichise, Sentaro Kusuhara, Naokazu Muramae, Kenta Mori, Kazunori Otsui, Kazuhiko Sakaguchi. Glucocorticoid in Combination with a TNF-α Inhibitor: Treatment of Deep Vein Thrombosis in a Patient with Behçet's Disease. Internal medicine (Tokyo, Japan). 2023. 62. 13. 2009-2012
  • Tomoko Yamada, Shun-Ichiro Asahara, Maki Kimura-Koyanagi, Yoshikazu Tamori, Naokazu Muramae, Kenta Mori, Mitsumasa Okano, Kazunori Otsui, Kazuhiko Sakaguchi. Distinct hypoglycemic effect of different formulations of a fixed ratio of basal insulin plus glucagon-like peptide-1 receptor agonist in a patient with pancreatic diabetes. Diabetology international. 2023. 14. 3. 294-297
  • Yoshito Sugi, Kenta Mori, Takashi Kobayashi, Naoki Arai, Mitsumasa Okano, Naokazu Muramae, Toshihiko Oshita, Kazunori Otsui, Kazuhiko Sakaguchi. Panhypopituitarism Mimicking Acute Coronary Syndrome. Internal medicine (Tokyo, Japan). 2023. 62. 4. 559-564
  • Yutaka Ishibashi, Hiroshi Yoshida, Kazuhiko Kotani, Yusuke Akiyama, Hisako Fujii, Mariko Harada-Shiba, Tatsuro Ishida, Yasushi Ishigaki, Daijiro Kabata, Yasuki Kihara, et al. Serum Values of Cholesterol Absorption and Synthesis Biomarkers in Japanese Healthy Subjects: The CACHE Study HEALTHY Analysis. Journal of Atherosclerosis and Thrombosis. 2023
more...
MISC (11):
  • 尾下 寿彦, 杜 隆嗣, 篠原 正和, 森 健太, 入野 康宏, 長尾 学, 原 哲也, 大竹 寛雅, 石田 達郎, 平田 健一. 日本人において血清トランス脂肪酸濃度の上昇は経皮的冠動脈インターベンション後の再血行再建術発生の独立したリスク因子となる. 日本動脈硬化学会総会プログラム・抄録集. 2019. 51回. 2-3
  • 森健太, 乙井一典, Hirata Ken-ichi. 【診断と治療のABC[138]高TG血症】 (第4章)管理・治療 高TG血症の管理と治療 治療薬剤 多価不飽和脂肪酸. 最新医学. 2018. 別冊高TG血症. 133-142
  • Amane Harada, Ryuji Toh, Katsuhiro Murakami, Maria Kiriyama, Keiko Yoshikawa, Takuya Kubo, Keiko Miwa, Yasuhiro Irino, Kenta Mori, Nobuaki Tanaka, et al. Cholesterol Uptake Capacity, a Novel Measure of High Density Lipoprotein Functionality for Coronary Risk Stratification. CIRCULATION. 2016. 134
  • Tetsuya Hara, Tomoko Monguchi, Masaya Akashi, Noriko Iwamoto, Kenta Mori, Ryuji Toh, Yasuhiro Irino, Masakazu Shinohara, Mikio Furuse, Tatsuro Ishida, et al. Targeted Disruption of JCAD/KIAA1462, a Coronary Artery Disease-associated Gene Product, Inhibits Angiogenic Processes in Vitro and in Vivo. CIRCULATION. 2015. 132
  • Tomoyuki Honjo, Ryuji Toh, Nobuaki Tanaka, Masato Mitsuhashi, Kenta Mori, Takeshige Mori, Manabu Nagao, Tatsuro Ishida, Ken-ichi Hirata. EX VIVO SIMULATION OF THE IMMUNE RESPONSE AGAINST OXDIZED LOW-DENSITY LIPOPROTEIN AS ANEW RISK STRATIFICATION IN CORONARY ARTERY DISEASE. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2015. 65. 10. A1604-A1604
more...
Books (2):
  • 診断と治療のABC 138 高TG血症
    最新醫學社 2018
  • 冠動脈疾患のパーフェクトマネジメント
    南江堂 2013
Lectures and oral presentations  (5):
  • Reduction of 5-Lipoxygenase Derived Docosahexaenoic Acid Metabolites Under Social Mental Stress: Their Function for Maintenance of Heme Oxygenase-1 Expression in Macrophage
    (American Heart Association's 2018 Scientific Sessions 2018)
  • Elevation of Serum Trans-fatty Acids Level as a Possible Risk for Target Lesion Revascularization After Coronary Intervention
    (第66回 日本心臓病学会学術集会 2018)
  • Real-Time in Vivo Imaging of Thrombosis Initiated by Red Blood Cell Aggregation in Novel Murine Stasis Model of DVT
    (第50回 日本動脈硬化学会総会・学術集会 2018)
  • Role of exogenous lipids in progression of coronary lesion during LDL-C lowering therapy
    (The 15th Annual Meeting of Japanese Society of Hospital General Medicine 2017)
  • Elevated serum trans-fatty acid as a risk for cardiovascular event recurrence in Japan
    (The 49th Annual Scientific Meeting of the Japan Atherosclerosis Society 2017)
Education (2):
  • 2010 - 2014 Kobe University Graduate School of Medicine
  • 1999 - 2005 Hyogo College of Medicine
Professional career (1):
  • 博士(医学) (神戸大学)
Work history (4):
  • 2024/04 - 現在 Toyooka Hospital
  • 2017/04 - 2024/03 Kobe University University Hospital
  • 2015/08 - 2017/03 University of California, Davis, CA, the U.S Molecular Biosciences / Nutrition Pos-Doc Fellow
  • 2014/04 - 2015/07 Kobe University Graduate School of Medicine, Japan Cardiovascular Medicine Research Fellow
Committee career (1):
  • 2018/05 - 現在 動脈硬化学会 評議委員
Awards (4):
  • 2018 - Asian-Pacific Society of Atherosclerosis and Vascular Disease APSAVD-JAS Joint Symposium - Invitation Presenter
  • 2016/03 - The Japan Circulation Society 2016 Circulation Journal Award of the Year 2015, Clinical Investigation Section The paper published in Circulation Journal
  • 2015 - Sumitomo Life Welfare and Culture Foundation, Overseas Grant
  • 2011 - AHA ATVB Early Career Networking Reception
Association Membership(s) (5):
THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  THE JAPANESE ASSOCIATION OF REHABILITATION MEDICINE ,  日本病院総合診療学会 ,  JAPAN ATHEROSCLEROSIS SOCIETY ,  The Japanese Circulation Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page